[HTML][HTML] Prospective, Observational Study of Aflibercept Use in Combination with FOLFIRI in Patients with Metastatic Colorectal Cancer: A Real-World Effectiveness …
A Durbajło, M Świeżyński, B Ziemba… - Cancers, 2024 - mdpi.com
Simple Summary The VELOUR randomized phase III trial established aflibercept (an anti-
angiogenic targeting VEGF-A, VEGF-B, and placenta growth factor) combined with FOLFIRI …
angiogenic targeting VEGF-A, VEGF-B, and placenta growth factor) combined with FOLFIRI …
Prospective, Observational Study of Aflibercept Use in Combination with FOLFIRI in Patients with Metastatic Colorectal Cancer: A Real-World Effectiveness Study
A Durbajło, M Świeżyński, B Ziemba… - …, 2024 - pubmed.ncbi.nlm.nih.gov
Background This was an observational study prospectively evaluating the effectiveness and
safety of aflibercept/FOLFIRI administered in second-line mCRC per the reimbursement …
safety of aflibercept/FOLFIRI administered in second-line mCRC per the reimbursement …
Prospective, Observational Study of Aflibercept Use in Combination with FOLFIRI in Patients with Metastatic Colorectal Cancer: A Real-World Effectiveness Study.
A Durbajło, M Świeżyński, B Ziemba… - …, 2024 - search.ebscohost.com
Abstract Simple Summary: The VELOUR randomized phase III trial established aflibercept
(an anti-angiogenic targeting VEGF-A, VEGF-B, and placenta growth factor) combined with …
(an anti-angiogenic targeting VEGF-A, VEGF-B, and placenta growth factor) combined with …
[HTML][HTML] Prospective, Observational Study of Aflibercept Use in Combination with FOLFIRI in Patients with Metastatic Colorectal Cancer: A Real-World Effectiveness …
A Durbajło, M Świeżyński, B Ziemba… - Cancers, 2024 - ncbi.nlm.nih.gov
Background: This was an observational study prospectively evaluating the effectiveness and
safety of aflibercept/FOLFIRI administered in second-line mCRC per the reimbursement …
safety of aflibercept/FOLFIRI administered in second-line mCRC per the reimbursement …